Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,614
in 3 filings

Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wilson Martin −$384K General Counsel sold 19% of stake
  2. Chaudhuri Sarbani −$11K See Remarks sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-13 WONG RODERICK Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 WONG RODERICK Director Grant or award · Stock Option (Right to Buy) +3,325 $15.04 $50K 3,325
2024-06-13 SOUTHWELL DAVID P Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 Yalamanchi Naveen Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 Malik Fady Ibraham Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 Makker Gotham Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 Makker Gotham Director Grant or award · Stock Option (Right to Buy) +2,660 $15.04 $40K 2,660
2024-06-13 GRANADILLO PEDRO P Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-06-13 GRANADILLO PEDRO P Director Grant or award · Stock Option (Right to Buy) +4,655 $15.04 $70K 4,655
2024-06-13 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2024-05-17 Schwartz Jonathan David See Remarks Sale −2,754 $23.35 $64K 169,659
2024-05-16 Militello John See Remarks Sale −1,079 $23.35 $25K 53,327
2024-05-16 Shah Gaurav CEO Sale −9,790 $23.35 $229K 728,069
2024-05-16 Wilson Martin General Counsel Sale −1,048 $23.35 $24K 65,762
2024-05-16 Patel Kinnari See Remarks Sale −4,046 $23.35 $94K 400,972
2024-05-14 Shah Gaurav CEO Option exercise +7,979 636,451
2024-05-14 Shah Gaurav CEO Option exercise +9,683 646,134
2024-05-14 Shah Gaurav CEO Option exercise · Restricted Stock Units −7,979 23,940
2024-05-14 Shah Gaurav CEO Option exercise · Restricted Stock Units −9,683 67,785
2024-05-14 Wilson Martin General Counsel Option exercise +2,420 21,100

Page 10 of 19 · 374 trades